title: Regorafenib Also Can Cause Osteonecrosis of the Jaw.
authors: S.C Oncologia Medica, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy (LA, AL, EG, MB, FDC). lorenzo.antonuzzo@gmail.com.
authors: Lorenzo
authors: L
authors: Antonuzzo
authors: S.C Oncologia Medica, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy (LA, AL, EG, MB, FDC).
authors: Alice
authors: A
authors: Lunghi
authors: S.C Oncologia Medica, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy (LA, AL, EG, MB, FDC).
authors: Elisa
authors: E
authors: Giommoni
authors: S.C Oncologia Medica, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy (LA, AL, EG, MB, FDC).
authors: Marco
authors: M
authors: Brugia
authors: S.C Oncologia Medica, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy (LA, AL, EG, MB, FDC).
authors: Francesco
authors: F
authors: Di Costanzo
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D010671:Phenylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D011725:Pyridines; C559147:regorafenib